MONECO Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Buy |
10,325
+275
| +3% | +$10.6K | 0.04% | 336 |
|
|
2025
Q1 | $389K | Sell |
10,050
-572
| -5% | -$22.2K | 0.04% | 322 |
|
|
2024
Q4 | $359K | Sell |
10,622
-1,696
| -14% | -$57.4K | 0.04% | 338 |
|
|
2024
Q3 | $504K | Buy |
12,318
+744
| +6% | +$30.4K | 0.06% | 256 |
|
|
2024
Q2 | $446K | Sell |
11,574
-611
| -5% | -$23.5K | 0.07% | 253 |
|
|
2024
Q1 | $522K | Sell |
12,185
-248
| -2% | -$10.6K | 0.08% | 232 |
|
|
2023
Q4 | $461K | Buy |
12,433
+346
| +3% | +$12.8K | 0.09% | 224 |
|
|
2023
Q3 | $438K | Buy |
12,087
+3,444
| +40% | +$125K | 0.12% | 201 |
|
|
2023
Q2 | $308K | Buy |
8,643
+314
| +4% | +$11.2K | 0.08% | 250 |
|
|
2023
Q1 | $296K | Buy |
8,329
+1,835
| +28% | +$65.3K | 0.09% | 242 |
|
|
2022
Q4 | $228K | Buy |
+6,494
| New | +$228K | 0.08% | 232 |
|